am 251 and oxadiazoles

am 251 has been researched along with oxadiazoles in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gitlin, JM; Mitchell, JA; Stanford, SJ1
Dillon, GM; Dodart, JC; Ferguson, MT; Fong, TM; Hale, JJ; Huang, RR; Kornecook, TJ; Lao, JZ; Lubbers, LS; Miao, S; Rowe, BA; Rupprecht, K; Xiao, JC1
Aguiar, JC; Guimarães, FS; Lisboa, SF; Magesto, AC; Resstel, LB1
Bojanowska, E; Drobnik, J; Juszczak, M; Wierucka-Rybak, M; Wolak, M1

Other Studies

4 other study(ies) available for am 251 and oxadiazoles

ArticleYear
Identification of two distinct vasodilator pathways activated by ATP in the mesenteric bed of the rat.
    British journal of pharmacology, 2001, Volume: 133, Issue:6

    Topics: Adenine; Adenosine; Adenosine Triphosphate; Animals; Arachidonic Acids; Capsaicin; Dose-Response Relationship, Drug; Endocannabinoids; Endothelium, Vascular; Enzyme Inhibitors; Guanylate Cyclase; Histamine; In Vitro Techniques; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxadiazoles; Piperidines; Polyunsaturated Alkamides; Potassium Chloride; Pyrazoles; Pyrilamine; Quinoxalines; Rats; Rats, Wistar; Rimonabant; Signal Transduction; Stereoisomerism; Theophylline; Vasodilation

2001
MK-7128, a novel CB1 receptor inverse agonist, improves scopolamine-induced learning and memory deficits in mice.
    Behavioural pharmacology, 2011, Volume: 22, Issue:2

    Topics: Animals; Azetidines; Cerebral Cortex; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Inverse Agonism; Hippocampus; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Oxadiazoles; Piperidines; Protein Binding; Pyrazoles; Receptor, Cannabinoid, CB1; Scopolamine

2011
Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats.
    Neuropharmacology, 2013, Volume: 75

    Topics: Animals; Anxiety; Apomorphine; Arachidonic Acids; Bicuculline; Cannabinoid Receptor Agonists; Disease Models, Animal; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; GABA-A Receptor Antagonists; Male; Maze Learning; Nitric Oxide Synthase; Oxadiazoles; Periaqueductal Gray; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Quinoxalines; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1

2013
The inhibitory effect of combination treatment with leptin and cannabinoid CB1 receptor agonist on food intake and body weight gain is mediated by serotonin 1B and 2C receptors.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2016, Volume: 67, Issue:3

    Topics: Aminopyridines; Animals; Cannabinoid Receptor Agonists; Drug Synergism; Eating; Indoles; Leptin; Male; Oxadiazoles; Piperazines; Piperidines; Pyrazoles; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Weight Gain

2016
chemdatabank.com